References

Coles, G.A. and N. Topley, 2000. Long-term peritoneal membrane changes. Adv. Ren. Replace Ther., 7: 289-301.
PubMed  |  

Davies, S.J., L. Philipps, R.F. Naish and G.I. Russell, 2001. Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal dialysis. J. Am. Soc. Nephrol., 12: 1046-1051.
PubMed  |  Direct Link  |  

De Vriese, A.S., R.G. Tilton, C.C. Stephan and N.H. Lameire, 2001. Vascular endothelial growth factor is essential for hyperglycemia-induced structural and functional alterations of the peritoneal membrane. J. Am. Soc. Nephrol., 12: 1734-1741.
PubMed  |  Direct Link  |  

De Vriese, A.S., S. Mortier, M. Cornelissen, E. Palmans and N.J. Vanacker et al., 2002. The effects of heparin administration in an animal model of chronic peritoneal dialysate exposure. Perit. Dial. Int., 22: 566-572.
PubMed  |  Direct Link  |  

Devuyst, O., 2001. Molecular mechanisms of peritoneal permeability-research in growth factors. Perit. Dial. Int., 21: S19-S23.
PubMed  |  

Di Paolo, N., G. Garosi, G. Petrini, L. Traversari and P. Rossi, 1995. Peritoneal dialysis solution biocompatibility testing in animals. Perit. Dial. Int., 15: S61-S69.
PubMed  |  

Di Paolo, N., G. Sacchi, M. De Mia, E. Gaggiotti and L. Capotondo et al., 1986. Morphology of the peritoneal membrane during continuous ambulatory peritoneal dialysis. Nephron, 44: 204-211.
CrossRef  |  PubMed  |  

Flessner, M.F., J. Choi, H. Vanpelt, Z. He, K. Credit, J. Henegar and M. Hughson, 2006. Correlating structure with solute and water transport in a chronic model of peritoneal inflammation. Am. J. Physiol. Renal Physiol., 290: F232-F240.
CrossRef  |  PubMed  |  

Hekking, L.H.P., M. Zareie, B.A.J. Driesprong, D. Faict and A.G. Welten et al., 2001. Better preservation of peritoneal morphologic features and defense in rats after long-term exposure to a bicarbonate/lactate-buffered solution. J. Am. Soc. Nephrol., 12: 2775-2786.
PubMed  |  Direct Link  |  

Honda, K., K. Nitta, S. Horita, W. Yumura and H. Nihei et al., 1999. Accumulation of advanced glycation end products in the peritoneal vasculature of continuous ambulatory peritoneal dialysis patients with low ultrafiltration. Nephrol. Dial. Transplant., 14: 1541-1549.
PubMed  |  Direct Link  |  

Jorres, A. and J. Witowski, 2005. Lessons from basic research for PD treatment. Perit. Dial. Int., 25: S35-S38.
PubMed  |  Direct Link  |  

Margetts, P.J., M. Kolb, L. Yu, C.M. Hoff and J. Gauldie, 2001. A chronic inflammatory infusion model of peritoneal dialysis in rats. Perit. Dial. Int., 21: S368-S372.
PubMed  |  Direct Link  |  

Margetts, P.J., M. Kolb, L. Yu, C.M. Hoff, C.J. Holmes, D.C. Anthony and J. Gauldie, 2002. Inflammatory cytokines, angiogenesis and fibrosis in the rat peritoneum. Am. J. Pathol., 160: 2285-2294.
CrossRef  |  PubMed  |  

Margetts, P.J., M. Kolb, T. Galt, C.M. Hoff, T.R. Shockley and J. Gauldie, 2001. Gene transfer of transforming growth factor-β1 to the rat peritoneum: Effects on membrane function. J. Am. Soc. Nephrol., 12: 2029-2039.
PubMed  |  Direct Link  |  

Mortier, S., A.S. De Vriese, A. Leyssens, N.J. Vanacker and D. Faict et al., 2003. Antibiotic administration in an animal model of chronic peritoneal dialysate exposure. Perit. Dial. Int., 23: 331-338.
PubMed  |  Direct Link  |  

Mortier, S., N.H. Lamiere and A.S. De Vriese, 2005. Animal models in peritoneal dialysis research: A need for consensus. Perit. Dial. Int., 25: 16-24.
PubMed  |  Direct Link  |  

Musi, B., O. Carlsson, A. Rippe, A. Wieslander and B. Rippe, 1998. Effects of acidity, glucose degradation products and dialysis fluid buffer choice on peritoneal solute and fluid transport in rats. Perit. Dial. Int., 18: 303-310.
PubMed  |  

Nakayama, M., Y. Kawaguchi, K. Yamada, T. Hasegawa and K. Takazoe et al., 1997. Immunohistochemical detection of advanced glycosylation end-products in the peritoneum and its possible pathophysiological role in CAPD. Kidney Int., 51: 182-186.
CrossRef  |  PubMed  |  

Peng, W.X., Q.Y. Guo, S.M. Liu, C.Z. Liu, B. Lindholm and T. Wang, 2000. Comparison of three chronic dialysis models. Adv. Perit. Dial., 16: 51-54.
PubMed  |  Direct Link  |  

Schambye, H.T., P. Flesner, R.B. Pedersen, M. Hardt-Madsen and J. Chemnitz et al., 1992. Bicarbonate-versus lactate-based CAPD fluids: A biocompatibility study in rabbits. Perit. Dial. Int., 12: 281-286.
PubMed  |  Direct Link  |  

Smit, W., A. Parikova, D.G. Strujik and R.T. Krediet, 2005. The difference in causes of early and late ultrafiltration failure in peritoneal dialysis. Perit. Dial. Int., 25: S41-S45.
PubMed  |  Direct Link  |  

Stojimirovic, B., J. Trbojevic-Stankovic and D. Nesic, 2007. Animal models in peritoneal dialysis. Scand. J. Lab. Anim. Sci., 34: 283-289.
Direct Link  |  

Stojimirovic, B.B., M.M. Obradovic, D.P. Trpinac, D.D. Milutinovic, D.I. Obradovic and V.B. Nesic, 2001. Mesothelial paracrystalline inclusions in continuous ambulatory peritoneal dialysis patients. Perit. Dial. Int., 21: S54-S57.
PubMed  |  Direct Link  |  

Topley, N., 2005. Animal models in peritoneal dialysis: More questions than answers. Perit. Dial. Int., 25: 33-34.
PubMed  |  Direct Link  |  

Trbojevic-Stankovic, J., Z. Milicevic, Z. Lausevic, N. Milicevic, M. Obradovic and B. Stojimirovic, 2007. Histomorphometric characteristics of peritoneal blood microvessels. Med. Pregl., 60: 58-61.
PubMed  |  Direct Link  |  

Wieczorowska-Tobis, K., K. Korybalska, A. Polubinska, M. Radkowski, A. Breborowicz and D.G. Oreopoulos, 1997. In vivo model to study the biocompatibility of peritoneal dialysis solutions. Int. J. Artif. Organs, 20: 673-677.
PubMed  |  

Wieczorowska-Tobis, K., R. Brelinska, J. Witowski, J. Passlick-Deetjen, T.P. Schaub, H. Schilling and A. Breborowicz, 2004. Evidence for less irritation to the peritoneal membrane in rats dialyzed with solutions low in glucose degradation products. Perit. Dial. Int., 24: 48-57.
PubMed  |  Direct Link  |  

Wieslander, A., T. Linden, B. Musi, O. Carlsson and R. Deppisch, 2000. Biological significance of reducing glucose degradation products in peritoneal dialysis fluids. Perit. Dial. Int., 20: S23-S27.
PubMed  |  Direct Link  |  

Williams, J.D., K.J. Craig, N. Topley, C.V. Ruhland and M. Fallon et al., 2002. Morphologic changes in the peritoneal membrane of patients with renal disease. J. Am. Soc. Nephrol., 13: 470-479.
PubMed  |  Direct Link  |  

Witowski, J. and A. Jorres, 2005. Effects of peritoneal dialysis solutions on the peritoneal membrane: Clinical consequences. Perit. Dial. Int., 25: S31-S34.
Direct Link  |  

Witowski, J., K. Korybalska, J. Wisniewska, A. Breborowicz and G.M. Gahl et al., 2000. Effect of glucose degradation products on human peritoneal mesothelial cell function. J. Am. Soc. Nephrol., 11: 729-739.
PubMed  |  Direct Link  |  

Zareie, M., L.H.P. Hekking, A.G.A. Welten, B.A.J. Driesprong and I.L. Schadee-Eestermans et al., 2003. Contribution of lactate buffer, glucose and glucose degradation products to peritoneal injury in vivo. Nephrol. Dial. Transplant., 18: 2629-2637.
CrossRef  |  PubMed  |  

Zunic-Bozinovski, S., B. Stojimirovic, Z. Lausevic, S. Krstic, J. Trbojevic-Stankovic and N. Jovanovic, 2008. Modification of peritoneal dialysis model on rabbits: Pilot study. Srp. Arh. Celok. Lek., 136: 38-43.

Zweers, M.M., C.E. Douma, D.R. de Waart, A.B. van der Wardt, M.M. Ho-dac-Pannekeet, R.T. Krediet and D.G. Struijk, 1999. The standard peritoneal permeability analysis in the rabbit: A longitudinal model for peritoneal dialysis. Perit. Dial. Int., 19: 56-64.
PubMed  |  Direct Link  |  

Zweers, M.M., J. Splint, R.T. Krediet and D.G. Struijk, 2001. Ultrastructure of basement membranes of peritoneal capillaries in a chronic peritoneal infusion model in the rat. Nephrol. Dial. Transplant., 16: 651-654.
CrossRef  |  PubMed  |